1. Market Research
  2. > EirGen Pharma Ltd. - Product Pipeline Review - 2013

EirGen Pharma Ltd. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 20 pages

EirGen Pharma Ltd. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “EirGen Pharma Ltd. - Product Pipeline Review - 2013” provides data on the EirGen Pharma Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, EirGen Pharma Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from EirGen Pharma Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- EirGen Pharma Ltd. - Brief EirGen Pharma Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of EirGen Pharma Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of EirGen Pharma Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the EirGen Pharma Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate EirGen Pharma Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of EirGen Pharma Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the EirGen Pharma Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with EirGen Pharma Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of EirGen Pharma Ltd. and identify potential opportunities in those areas.

Table Of Contents

EirGen Pharma Ltd. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
EirGen Pharma Ltd. Snapshot 4
EirGen Pharma Ltd. Overview 4
Key Information 4
Key Facts 4
EirGen Pharma Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
EirGen Pharma Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
EirGen Pharma Ltd. - Pipeline Products Glance 9
EirGen Pharma Ltd. - Late Stage Pipeline Products 9
Pre-Registration Products/Combination Treatment Modalities 9
EirGen Pharma Ltd. - Unknown Stage Pipeline Products 10
Unknown Products/Combination Treatment Modalities 10
EirGen Pharma Ltd. - Drug Profiles 11
Eir-060 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Eir-070 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Eir-099 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Eir-075 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Eir-108 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
EirGen Pharma Ltd. - Pipeline Analysis 16
EirGen Pharma Ltd. - Pipeline Products by Therapeutic Class 16
EirGen Pharma Ltd. - Pipeline Products by Molecule Type 17
EirGen Pharma Ltd. - Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
Coverage 19
Secondary Research 19
Primary Research 19
Expert Panel Validation 19
Contact Us 20
Disclaimer 20



List of Tables

EirGen Pharma Ltd., Key Information 4
EirGen Pharma Ltd., Key Facts 4
EirGen Pharma Ltd. - Pipeline by Indication, 2013 6
EirGen Pharma Ltd. - Pipeline by Stage of Development, 2013 7
EirGen Pharma Ltd. - Monotherapy Products in Pipeline, 2013 8
EirGen Pharma Ltd. - Pre-Registration, 2013 9
EirGen Pharma Ltd. - Unknown, 2013 10
EirGen Pharma Ltd. - Pipeline by Therapeutic Class, 2013 16
EirGen Pharma Ltd. - Pipeline by Molecule Type, 2013 17



List of Figures

EirGen Pharma Ltd. - Pipeline by Top 10 Indication, 2013 6
EirGen Pharma Ltd. - Pipeline by Stage of Development, 2013 7
EirGen Pharma Ltd. - Monotherapy Products in Pipeline, 2013 8
EirGen Pharma Ltd. - Pipeline by Top 10 Therapeutic Class, 2013 16



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.